Article
Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review.
Medicine - 1 Nov 2017
Feng Chunyue, Wang Qiong, Wang Jingjing, Liu Fei, Shen Huijun, Fu Haidong, Mao Jianhua
Abstract excerpt
RATIONALE: Mitochondrial nephropathy has a poor prognosis and often progresses to the end-stage renal disease. Renal pathology often is focal segmental glomerulosclerosis (FSGS) and does not respond to steroid therapy or immunosuppressive therapy. Some patients are benefited from the therapy of coenzyme Q10, which affect the synthesis pathway of coenzyme Q10. PATIENT CONCERNS: Herein, we report 2 cases of...
Topics
Join the communities discussing this publication.